Product Information
HYDROCODONE-ACETAMINOPHEN 7.5-325 MG/15 ML SOLUTION is a generic product labeled by Eywa Pharma Inc, priced at $0.2455 per ML under NDC 71930002743. Its NADAC has been published 383 times since Jun 5, 2019.
FDA first approved this application on Mar 8, 2019. Its Orange Book therapeutic-equivalence code is AA.
HYDROCODONE-ACETAMINOPHEN 7.5-325 MG/15 ML SOLUTION
Hydrocodone Bitartrate and AcetaminophenStrength
325; 7.5 mg/15mL; mg/15mL
Manufacturer
Eywa Pharma IncNDC
71930002743
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHEN; HYDROCODONE BITARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA211023FDA Approved
3/8/2019
TE Code
AA
On Market Since
4/8/2019
Pharmacological Classes
Price Statistics
The NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG/15 ML SOLUTION has been published 383 times since Jun 5, 2019, and over the history we have for it it has risen 156.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2455 per ML |
|---|---|
| All-time high | $0.3492 (Jun 12, 2024) |
| All-time low | $0.0444 (Jun 21, 2023) |
| 52-week high | $0.2575 |
| 52-week low | $0.2053 |
| Median price | $0.0800 |
| Average price | $0.1373 |
| Largest weekly change | +462.7% (Apr 10, 2024) |
| Weeks tracked | 383 |
| Tracking since | Jun 5, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Hydrocodone Bitartrate and Acetaminophen market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Eywa Pharma Inc manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Hydrocodone Bitartrate and Acetaminophen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HYDROCODONE-ACETAMINOPHEN 7.5-325 MG/15 ML SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG/15 ML SOLUTION, manufactured by Eywa Pharma Inc, is $0.2455 per ML (NDC 71930002743), effective Sep 30, 2026.
How has the price of HYDROCODONE-ACETAMINOPHEN 7.5-325 MG/15 ML SOLUTION changed over time?
Over the history we have for it, the NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG/15 ML SOLUTION has risen 156.7%. It has been tracked across 383 weekly CMS publications since Jun 5, 2019.
What are the highest and lowest recorded NADAC prices for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG/15 ML SOLUTION?
Since Jun 5, 2019, the NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG/15 ML SOLUTION has ranged from a low of $0.0444 (Jun 21, 2023) to a high of $0.3492 (Jun 12, 2024), with a median of $0.0800 per ML.
Are there cheaper alternatives to HYDROCODONE-ACETAMINOPHEN 7.5-325 MG/15 ML SOLUTION?
No other NADAC-published product currently shares the active ingredient and strength of HYDROCODONE-ACETAMINOPHEN 7.5-325 MG/15 ML SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures HYDROCODONE-ACETAMINOPHEN 7.5-325 MG/15 ML SOLUTION?
HYDROCODONE-ACETAMINOPHEN 7.5-325 MG/15 ML SOLUTION (NDC 71930002743) is labeled by Eywa Pharma Inc, and CMS classifies it as a generic product.